Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Investment firm agrees to acquire MedAssets and divest one of its segments

Pamplona Capital Management agreed to acquire MedAssets for approximately $2.7 billion or $31.35 per share in cash, the companies announced on Nov. 2. Pending shareholder approval and other closing conditions, the deal is expected to close in the first quarter of 2016.

Thumbnail

IPC Healthcare’s EBITDA decreases in 3rd quarter

IPC Healthcare’s revenue for the third quarter of 2015 increased 8.9 percent to $184.8 million, although its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) decreased 20.6 percent to $14.3 million compared with the same period last year.

MedAssets to be Acquired by Pamplona Capital Management for $2.7 Billion

MedAssets, Inc. (NASDAQ:MDAS) and Pamplona Capital Management today announced that they have entered into a definitive agreement whereby Pamplona will acquire MedAssets for $31.35 per share in cash.

Thumbnail

CMS reports smooth ICD-10 transition to date

The transition to ICD-10 is going well, according to the first numbers released by the Centers for Medicare & Medicaid Services. 

Thumbnail

EHR data fuels QI for neurology conditions

Rather than wait for EHR vendors to incorporate quality measures into their software, researchers from Evanston, Illinois-based NorthShore University HealthSystem created a quality improvement and practice-based initiative in neurology using their EHR. 

Thumbnail

Revenue, operating income increase for athenahealth in 3rd quarter

For the third quarter of fiscal 2015, athenahealth’s revenue increased 24 percent to $236.1 million compared with the same quarter in 2014, while its non-GAAP adjusted operating income increased from $18.5 million to $25.4 million during the same time period.

Survey shows information governance showing signs of maturity

Information governance is progressing, according to the results of the AHIMA-Cohasset Associates second survey on IG in Healthcare.  

Senators introduce bipartisan bills to expedite FDA approval for medical devices

Republican senator Cory Gardner (Colorado) and Democrat senator Joe Donnelly (Indiana) introduced two bills on Oct. 21 to accelerate the FDA approval process for medical devices.

Displaying 6409 - 6416 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.